BioCentury
ARTICLE | Company News

Becton Dickinson, Lab21 deal

October 22, 2012 7:00 AM UTC

Becton Dickinson's BD Diagnostics unit and Lab21 partnered to develop oncology assays for use on the BD's BD MAX system. Lab21 will develop PCR-based assays with an initial focus on two assays designe...